CareView Communications (CRVW) Asset Writedowns and Impairment (2012 - 2020)
CareView Communications' (CRVW) quarterly Asset Writedowns and Impairment came in at $21886.0 in Q1 2020, down 72.72% quarter-over-quarter from $80235.0 in Q4 2012.
Powered by 
Analysis
CareView Communications (CRVW) Asset Writedowns and Impairment (2012 - 2020) Analysis & Trends
CareView Communications has disclosed Asset Writedowns and Impairment across 2 years of filings, most recently posting $21886.0 for Q1 2020.
- In Q1 2020, Asset Writedowns and Impairment changed N/A year-over-year to $21886.0; the TTM figure through Sep 2020 stood at $21886.0 (changed N/A YoY), while the FY2023 annual figure was $334358.0, changed N/A from the prior year.
- Asset Writedowns and Impairment came in at $21886.0 for Q1 2020 at CareView Communications, down from $80235.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $21886.0 in Q1 2020 to a low of $21886.0 in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | CareView Communications | 23.36 Mn | 21.44 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 21,886.00 |
| Dec 31, 2012 | 80,235.00 |
| Sep 30, 2012 | -4,860.00 |
| Jun 30, 2012 | 4,860.00 |
| Mar 31, 2012 | -15,984.00 |